Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

POINTERRA LIMITED Regulatory Filings 2023

Oct 29, 2023

64255_rns_2023-10-29_ada7289d-3c56-4e6d-9536-2e022bca0a1e.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

ASX Announcement

30 October 2023

Additional Information - Response to ASX Query

Pointerra Limited (ASX: 3DP) (“Pointerra”; “Company”) provides the following additional information in relation to the Enterprise Sales Update announcement made on 30 October 2023.

Emesent Partnership

The agreement with Emesent contains an annual sales commitment of at least 50 Pointerra3D Core licenses. The initial term of the agreement is 1 year and will automatically extend for an additional 1 year unless terminated by either party, in writing at least 30 days prior to expiry of the initial term. The partnership will not incur additional costs for the Company. The partnership is not currently material and it is not currently possible to quantify any revenue impact.

Carbonix Partnership

The agreement with Carbonix does not contain any minimum sales or revenue targets for Pointerra. The term of the agreement is 2 years unless terminated by either party in writing giving 30 day’s notice. The partnership will not incur additional costs for the Company. The partnership is not currently material and it is not currently possible to quantify any revenue impact.

This announcement has been authorised and approved for release to the ASX by the Board of Pointerra Limited.

==> picture [109 x 26] intentionally omitted <==

Pointerra Limited | ABN 39 078 388 155 Registered Office: Level 4, 216 St Georges Terrace, Perth WA 6000 T +61 8 6268 2622 | F +61 8 6268 2699 | E [email protected] | W pointerra.com

| 1